For the Inventor, By the Inventor

Enter assignee name

Hamburg, Germany

Evotec Ag

USPTO Granted Patents = 24

CIPO Patents = 1

EPO Patents = 15

Trademarks = 3

Forward Citations = 22

Loading Chart...

Loading Chart...

52 inventors (with patents filed for the assignee):

John Kincaid (5 out of 19 patents)

Donogh John Roger O'Mahony (4 out of 11 patents)

Zhi-Liang Wei (4 out of 10 patents)

4. Carl J Kaub (4 out of 11 patents)

5. Zhan Wang (3 out of 21 patents)

6. David James Hallett (3 out of 3 patents)

7. Michael G Kelly (3 out of 72 patents)

8. Stefan Jäger (3 out of 3 patents)

9. Karsten Gall (3 out of 4 patents)

10. Adam James Davenport (2 out of 12 patents)

11. Matthew Duncton (2 out of 40 patents)

12. Kaupo Palo (2 out of 11 patents)

13. Peet Kask (2 out of 17 patents)

14. Yeyu Cao (2 out of 6 patents)

15. Sumithra Gowlugari (2 out of 6 patents)

24 patents: Sort by Forward Citations

1. 9759659 - Method for detecting the impacts of interfering effects on experimental data (2017-09-12),

2. 9133122 - Amide compounds, compositions and uses thereof (2015-09-15),

3. 8946439 - Amide compounds, compositions and uses thereof (2015-02-03),

4. 8912176 - Azetidines as histamine H3 receptor antagonists (2014-12-16),

5. 8859545 - Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases (2014-10-14),

6. 8691804 - Azetidines and cyclobutanes as histamine H3 receptor antagonists (2014-04-08),

7. 8653091 - Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof (2014-02-18),

8. 8623859 - Bradykinin B1 antagonists (2014-01-07),

9. 8580577 - Method for detecting an analyte in a sample (2013-11-12),

10. 8574861 - PPM1E proteins and nucleic acids as targets for neurodegenerative diseases (2013-11-05),

11. RE44555 - Method for analyzing chemical and/or biological samples by means of particle images (2013-10-21),

12. 8163901 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2012-04-24),

13. 8153651 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2012-04-10),

14. 8076345 - 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof (2011-12-13),

15. 7867707 - Method for detecting analytes in a sample (2011-01-11),

Evotec AG is a drug discovery and development company. It operates in two segments: EVT Execute and EVT Innovate. The EVT Execute segment provides standalone drug discovery solutions, while the EVT Innovate segment focuses on strategic partnerships with biotechnology and pharmaceutical companies to accelerate drug discovery and development. With a wide range of innovative technologies and expertise in multiple therapeutic areas, Evotec aims to drive forward drug discovery and improve the success rates of pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

24 Patents

#41 in Hamburg

#1,934 in Germany

#25,865 in the World

Hamburg, Germany

Evotec Ag

Forward Citations = 22

52 inventors:

John Kincaid (5 out of 19 patents)

Donogh John Roger O'Mahony (4 out of 11 patents)

Zhi-Liang Wei (4 out of 10 patents)

4. Carl J Kaub (4 out of 11 patents)

5. Zhan Wang (3 out of 21 patents)

Please report any incorrect information to support@idiyas.com

Loading…